Amsurg Corp. CEO Christopher A. Holden Sells 3,000 Shares (AMSG)
Amsurg Corp. (NASDAQ:AMSG) CEO Christopher A. Holden unloaded 3,000 shares of the stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $40.73, for a total value of $122,190.00. Following the completion of the transaction, the chief executive officer now directly owns 291,198 shares of the company’s stock, valued at approximately $11,860,495. The transaction was disclosed in a document filed with the SEC, which is available at this link.
A number of research firms have recently commented on AMSG. Analysts at Zacks reiterated a “neutral” rating on shares of Amsurg Corp. in a research note to investors on Thursday, January 2nd. They now have a $48.00 price target on the stock. Separately, analysts at Sidoti initiated coverage on shares of Amsurg Corp. in a research note to investors on Monday, December 9th. They set a “neutral” rating on the stock. Finally, analysts at Barclays initiated coverage on shares of Amsurg Corp. in a research note to investors on Monday, November 25th. They set an “equal weight” rating and a $52.00 price target on the stock. They noted that the move was a valuation call. Six equities research analysts have rated the stock with a hold rating, The stock currently has an average rating of “Hold” and a consensus price target of $44.80.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded down 0.32% on Thursday, hitting $40.73. 96,113 shares of the company’s stock traded hands. Amsurg Corp. has a one year low of $29.02 and a one year high of $48.71. The stock has a 50-day moving average of $44.35 and a 200-day moving average of $42.28. The company has a market cap of $1.313 billion and a P/E ratio of 18.68.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.